Daman Kumari1, Karen Usdin2. 1. Section on Genomic Structure and Function, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA damank@helix.nih.gov. 2. Section on Genomic Structure and Function, Laboratory of Cell and Molecular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Abstract
Expansion of a CGG-repeat tract in the 5'-untranslated region of the FMR1 gene to >200 repeats results in epigenetic silencing of the gene by a mechanism that is still unknown. FMR1 gene silencing results in fragile X syndrome (FXS), the most common heritable cause of intellectual disability. We have previously shown that reactivation of the FMR1 gene in FXS cells with 5-azadeoxycytidine (AZA) leads to the transient recruitment of EZH2, the polycomb repressive complex 2 (PRC2) component responsible for H3K27 trimethylation, and that this recruitment depends on the presence of the FMR1 transcript. However, whether H3K27 trimethylation was essential for FMR1 re-silencing was not known. We show here that EZH2 inhibitors increased FMR1 expression and significantly delayed re-silencing of the FMR1 gene in AZA-treated FXS cells. This delay occurred despite the fact that EZH2 inhibition did not prevent the return of DNA methylation. Treatment with compound 1a, a small molecule that targets CGG-repeats in the FMR1 mRNA, also resulted in sustained expression of the FMR1 gene in AZA-treated cells. This effect of 1a was also associated with a decrease in the levels of H3K27 trimethylation but not DNA methylation. Thus, our data show that EZH2 plays a critical role in the FMR1 gene silencing process and that its inhibition can prolong expression of the FMR1 gene even in the presence of its transcript.
Expansion of a CGG-repeat tract in the 5'-untranslated region of the FMR1 gene to >200 repeats results in epigenetic silencing of the gene by a mechanism that is still unknown. FMR1 gene silencing results in fragile X syndrome (FXS), the most common heritable cause of intellectual disability. We have previously shown that reactivation of the FMR1 gene in FXS cells with 5-azadeoxycytidine (AZA) leads to the transient recruitment of EZH2, the polycomb repressive complex 2 (PRC2) component responsible for H3K27 trimethylation, and that this recruitment depends on the presence of the FMR1 transcript. However, whether H3K27 trimethylation was essential for FMR1 re-silencing was not known. We show here that EZH2 inhibitors increased FMR1 expression and significantly delayed re-silencing of the FMR1 gene in AZA-treated FXS cells. This delay occurred despite the fact that EZH2 inhibition did not prevent the return of DNA methylation. Treatment with compound 1a, a small molecule that targets CGG-repeats in the FMR1 mRNA, also resulted in sustained expression of the FMR1 gene in AZA-treated cells. This effect of 1a was also associated with a decrease in the levels of H3K27 trimethylation but not DNA methylation. Thus, our data show that EZH2 plays a critical role in the FMR1 gene silencing process and that its inhibition can prolong expression of the FMR1 gene even in the presence of its transcript.
Authors: S J Boguslawski; D E Smith; M A Michalak; K E Mickelson; C O Yehle; W L Patterson; R J Carrico Journal: J Immunol Methods Date: 1986-05-01 Impact factor: 2.303
Authors: Kyle D Konze; Anqi Ma; Fengling Li; Dalia Barsyte-Lovejoy; Trevor Parton; Christopher J Macnevin; Feng Liu; Cen Gao; Xi-Ping Huang; Ekaterina Kuznetsova; Marie Rougie; Alice Jiang; Samantha G Pattenden; Jacqueline L Norris; Lindsey I James; Bryan L Roth; Peter J Brown; Stephen V Frye; Cheryl H Arrowsmith; Klaus M Hahn; Gang Greg Wang; Masoud Vedadi; Jian Jin Journal: ACS Chem Biol Date: 2013-04-24 Impact factor: 5.100
Authors: Daman Kumari; Aditi Bhattacharya; Jeffrey Nadel; Kristen Moulton; Nicole M Zeak; Anne Glicksman; Carl Dobkin; David J Brick; Philip H Schwartz; Carolyn B Smith; Eric Klann; Karen Usdin Journal: Hum Mutat Date: 2014-12 Impact factor: 4.878
Authors: Celine E F de Esch; Mehrnaz Ghazvini; Friedemann Loos; Nune Schelling-Kazaryan; W Widagdo; Shashini T Munshi; Erik van der Wal; Hannie Douben; Nilhan Gunhanlar; Steven A Kushner; W W M Pim Pijnappel; Femke M S de Vrij; Niels Geijsen; Joost Gribnau; Rob Willemsen Journal: Stem Cell Reports Date: 2014-09-11 Impact factor: 7.765
Authors: Rujuta Yashodhan Gadgil; Eric J Romer; Caitlin C Goodman; S Dean Rider; French J Damewood; Joanna R Barthelemy; Kazuo Shin-Ya; Helmut Hanenberg; Michael Leffak Journal: J Biol Chem Date: 2020-09-01 Impact factor: 5.157
Authors: Samantha M Meyer; Christopher C Williams; Yoshihiro Akahori; Toru Tanaka; Haruo Aikawa; Yuquan Tong; Jessica L Childs-Disney; Matthew D Disney Journal: Chem Soc Rev Date: 2020-10-05 Impact factor: 54.564